Overview

A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether TH-302 in combination with Doxorubicin is safe and effective in the treatment of Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma.

Phase:

Phase 3

Details

Lead Sponsor:

Threshold Pharmaceuticals

Collaborator:

Sarcoma Alliance for Research through Collaboration (SARC)

Treatments:

Doxorubicin
Liposomal doxorubicin